Use of recombinant factor VIIa (Novoseven) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation

Anesth Analg. 2005 Sep;101(3):924. doi: 10.1213/01.ANE.0000173666.80578.49.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Brachial Artery*
  • Extracorporeal Membrane Oxygenation
  • Factor VIIa / adverse effects*
  • Factor VIIa / therapeutic use
  • Fatal Outcome
  • Female
  • Hemostasis
  • Humans
  • Infant, Newborn
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Subclavian Artery*
  • Thrombosis / chemically induced*

Substances

  • Recombinant Proteins
  • Factor VIIa